Clinical Trials Logo

Clinical Trial Summary

Virtual reality has been shown to reduce the pain experienced during medical procedures. The aim of this study is to determine to what extent the use of this technique could make it possible to defer the administration of neuroleptanalgesia during the endovenous thermal treatment of superficial varicose veins in addition to local anaesthesia by tumescence.


Clinical Trial Description

The main objective of the study is to test the non-inferiority of the effect of sedation by the virtual reality device on the intensity of maximum intraoperative pain compared with the usual neuroleptanalgesic treatment, tolerating a margin of non-inferiority of 0.5 points.Pain will be assessed on an ENS immediately at the end of the surgical procedure. Prospective, randomised, open-label, single-centre study in two parallel groups of 200 patients. Maximum duration of patient participation in the study = 2 days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06228365
Study type Interventional
Source GCS Ramsay Santé pour l'Enseignement et la Recherche
Contact Lauranne MATRAY, MD
Phone 05 61 37 81 81
Email dr.lmatray.union@gmail.com
Status Recruiting
Phase N/A
Start date November 20, 2023
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT04304937 - Validation of Swedish Short PROM för Venous Insufficiency